A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine

Clinical Therapeutics

Volumn 23, Issue 7, 2001, Pages 1040-1058

  Coleman, Charles C ^a,e   King, Benjamin R ^b   Bolden Watson, Carolyn ^b   Book, Martin J ^c   Taylor Segraves, R ^d   Richard, Nathalie ^b   Ascher, John ^b   Batey, Sharyn ^b   Jamerson, Brenda ^b   Metz, Alan ^b  

^a Mississippi Neuropsychiatric Clinic   (United States)

^b GLAXOSMITHKLINE   (United States)

^c Woodmont Psychiatric Associates   (United States)

^d METROHEALTH MEDICAL CENTER   (United States)

^e Paragon Center   (United States)

Author keywords

Antidepressant; Bupropion sustained release; Depression; Fluoxetine; Sexual dysfunction

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; FLUOXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SUSTAINED RELEASE PREPARATION; TREATMENT OUTCOME;

EID: 0034904246     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(01)80090-4     Document Type: Article

References (39)

1. Effect of SSRI antidepressants on ejaculation: A double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline
2. The role of serotonin in sexual dysfunction: Fluoxetine-associated orgasm dysfunction
3. Overview of sexual dysfunction complicating the treatment of depression
4. Modification of sexual functions by antidepressants
5. Psychotropics and sexuality
6. Fluvoxamine-associated sexual dysfunction
7. Effects of depression and antidepressants on sexual functioning
8. Antidepressant-induced sexual dysfunction
9. SSRI-induced sexual dysfunction: Fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients
10. Treatment of tricyclic antidepressant-induced orgasmic inhibition with cyproheptadine
11. Mood disorders: Pharmacological prevention of recurrence
12. Effects of psychotropic drugs on human erection and ejaculation
13. Sexual dysfunction during antidepressant treatment
14. Fluoxetine-induced sexual dysfunction
15. Fluoxetine-induced sexual dysfunction and an open trial of yohimbine
16. Psychoactive drugs and human sexual behavior: The role of serotonergic activity
17. Changes in monoamine turnover in forebrain areas associated with masculine sexual behavior: A microdialysis study
18. The efficacy of anti-serotoninergic agents in the treatment of erectile dysfunction
19. Different roles of catecholaminergic and serotoninergic neurons in the medial forebrain bundle on male rat sexual behavior
20. Stimulation of spinal serotonergic receptors facilitates seminal emission and suppresses penile erectile reflexes
21. Bupropion: A review of its mechanism of antidepressant activity
22. Mechanism of antidepressant activity of bupropion
23. Double-blind comparison of bupropion sustained release and sertraline in depressed outpatients
24. A multicenter evaluation of the efficacy and safety of 150 and 300 mg/d sustained-release bupropion tablets versus placebo in depressed outpatients
25. A placebo-controlled comparison of the antidepressant and sexual functioning effects of sustained-release bupropion and sertraline
26. Sexual dysfunction associated with the treatment of depression: A placebo-controlled comparison of bupropion sustained release and sertraline treatment
27. Bupropion sustained release versus paroxetine for the treatment of depression in the elderly
28. Mood disorders
29. A rating scale for depression
30. Development of a rating scale for primary depressive illness
31. Redefining antidepressant efficacy toward long-term recovery
32. Efficacy, adverse events, and treatment discontinuations in fluoxetine clinical studies of major depression: A meta-analysis of the 20-mg/day dose
33. The role of the primary care physician in patients' adherence to antidepressant theraphy
34. Tolerability and patient compliance
35. Sexual side effects of antidepressants
36. Fluoxetine-induced sexual dysfunction
37. 2 antagonist, in the treatment of sexual dysfunction induced by serotonin reuptake inhibitors
38. The effect of selective 5-hydroxytryptamine uptake inhibitors on 5-methoxy-N,N-dimethyltriptamine-induced ejaculation in the rat